BDO advises ResMed Inc. on its acquisition of digital health company mementor with DiGA somnio

mementor was founded in Switzerland in 2014 and is now based in Leipzig, Germany. The health tech company developed the digital insomnia therapy solution somnio, which is Germany’s first and only permanently approved Digital Health Application (DiGA) in the field of sleep medicine and thus eligible for reimbursement in Germany. It’s also compliant with the European Union’s data protection requirements under the General Data Protection Regulation (GDPR).

Through the acquisition, mementor can leverage ResMed’s broader network in Germany to increase adoption of its approved digital therapy alternative for insomnia; somnio is available today in Germany via “app on prescription”. mementor will be integrated into ResMed in Germany as a separate business segment and will serve as a platform for further developments in the field of digital health. “mementor is an ideal fit for ResMed in Germany and, more important, millions of people across Germany who want to improve their sleep and overall health,” said Katrin Pucknat, President at ResMed Germany.

BDO’s multi-disciplinary team with specialists from M&A, Corporate Finance and Transaction Tax acted as exclusive financial advisor to ResMed Inc. on this transaction. Besides M&A advice the BDO team supported the ResMed deal team throughout the acquisition process in terms of financial due diligence, tax due diligence and Transaction Tax advice.

 

BDO advisors:

Matthias Meyer (M&A Advisory, Munich)

Elke Wollank (Financial Due Diligence, Munich)

Dr. Michael Brauer (Tax Due Diligence and Tax Structuring, Düsseldorf)

Philipp Baumeister (Tax Due Diligence and Tax Structuring, Düsseldorf)

Stefan Piller (Tax Due Diligence and Tax Structuring, BDO Zürich)

Judith Lorenz (Tax Due Diligence and Tax Structuring, BDO Zürich)

Saro Dinc (Tax Due Diligence and Tax Structuring, Düsseldorf)